Browsing by Author "99b3d1d1-10e4-4d38-82a6-7ece5f7cbed4"
Now showing items 1-4 of 4
-
Desarrollo de un proyecto profesional de creación de empresa periodística: Inforgráfica, S.L. Una apuesta por la información visual
Varella Montero, Paula Universitat Jaume I (2014-06-03)INFORGRÁFICA, S.L., is an infographic company that focuses on creating infographics for enterprises and a biweekly journal. Also referred to as “information graphics”, infographics are representations of information, data ... -
MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
MILARA, JAVIER; Díaz-Platas, Lucía; Contreras, Sonia; Ribera, Pilar; Roger, Inés; Ballester, Beatriz; Montero, Paula; Cogolludo, Ángel; Morcillo, Esteban; Cortijo, Julio BMC (2018)Background Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD ... -
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
Montero, Paula; Pérez-Leal, Martín; Pérez-Fidalgo, J. Alejandro; Sanz, Celia; Estornut, Cristina; Roger, Inés; MILARA, JAVIER; Cervantes, Andrés; Cortijo, Julio MDPI (2022-03-01)Background: Paclitaxel is a microtubule-stabilizing chemotherapeutic agent. Despite its widespread use, it damages healthy tissues such as skin. The goal of this study was to prove that the real impact of paclitaxel-induced ... -
Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model
Sanz, Celia; Montero, Paula; MILARA, JAVIER; Pérez-Leal, Martín; Estornut, Cristina; Roger, Inés; Pérez-Fidalgo, J. Alejandro; Cortijo, Julio MDPI (2022-01-22)Paclitaxel is a microtubule-stabilizing chemotherapeutic agent approved for the treatment of ovarian, non-small cell lung, head, neck, and breast cancers. Despite its beneficial effects on cancer and widespread use, ...